105 4–1BB and optimized CD28 co-stimulation enhances function of human mono- and bi-specific third-generation CAR T cells

• Yannick Bulliard,
• Bin Yu,
• Emiliano Roselli,
• Gongbo Li,
• Hiroshi Kotani,
• Kristen Spitler,
• Kayla Reid,
• Nhan Tu,
• Sae Bom Lee,
• Justin Boucher,
• Frederick Locke,
• Marco Davila

Affiliations

Yannick Bulliard

Atara Biotherapeutics Inc, Thousand Oaks, California, USA

Bin Yu

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Emiliano Roselli

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Gongbo Li

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Hiroshi Kotani

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Kristen Spitler

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Kayla Reid

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Nhan Tu

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Sae Bom Lee

Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Justin Boucher

1H. Lee Moffitt Cancer Center, Tampa, FL, USA

Frederick Locke

1H. Lee Moffitt Cancer Center, Tampa, FL, USA

Marco Davila

1H. Lee Moffitt Cancer Center, Tampa, FL, USA